BioCardia to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference on August 10, 2021

Rhea-AI Summary

BioCardia, a leader in cardiovascular therapies, will have its CEO, Peter Altman, participate in a fireside chat and one-on-one meetings at the BTIG Virtual Biotechnology Conference on August 10, 2021. The chat is scheduled from 3:30-3:55 pm ET. Interested attendees can register for the event, and a replay will be available for BTIG clients until the end of the day on August 10. BioCardia focuses on developing regenerative biologic therapies for cardiovascular and pulmonary diseases and offers advanced delivery systems for biotherapeutic applications.

SAN CARLOS, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, announced today that Chief Executive Officer, Peter Altman, will participate in a fireside chat as well as one on one meetings at the upcoming BTIG Virtual Biotechnology Conference being held August 9-10, 2021.

Fireside Chat Event Details:

BTIG Virtual Biotechnology Conference
Date: Tuesday, August 10, 2021
Time: 3:30-3:55 pm ET / 12:30-12:55 PT

Click here to register.

For those unable to attend, a replay of the presentation will be available until the end of the day Tuesday, August 10, 2021 on the BTIG conference website. You must be a BTIG client to attend and access the replay.  

About BioCardia®

BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and pulmonary disease. CardiAMP™ autologous and NK1R+ allogeneic cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company's current products include the Helix™ transendocardial delivery system, the Morph® steerable guide and sheath catheter portfolio and the AVANCE™ steerable introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and development support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit www.BioCardia.com.

INVESTOR CONTACT:
David McClung, Chief Financial Officer
investors@BioCardia.com
(650) 226-0120

MEDIA CONTACT:
Anne Laluc, Marketing
Email: alaluc@biocardia.com
Phone: 650-226-0120

FAQ

What is the date and time of BioCardia's fireside chat at the BTIG Virtual Biotechnology Conference?

BioCardia's fireside chat is scheduled for August 10, 2021, from 3:30 to 3:55 pm ET.

How can I register for the BTIG Virtual Biotechnology Conference featuring BioCardia?

You can register for the BTIG Virtual Biotechnology Conference through the conference website.

Will there be a replay available for BioCardia's presentation at the BTIG Conference?

Yes, a replay will be available until the end of the day on August 10, 2021, for BTIG clients.

Who is representing BioCardia at the BTIG Virtual Biotechnology Conference?

Peter Altman, the CEO of BioCardia, will represent the company at the conference.

What are BioCardia's main areas of focus in their therapies?

BioCardia focuses on developing regenerative biologic therapies for cardiovascular and pulmonary diseases.